Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC

Clinical trial NCT00755534 · TERMINATED

Trial details

NCT number: NCT00755534
Sponsor: Hellenic Oncology Research Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2008-11-01
Primary completion: 2008-11-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.